Wikisage, the free encyclopedia of the second generation, is digital heritage

Difference between revisions of "Drisapersen"

From Wikisage
Jump to navigation Jump to search
m (Links)
m
Line 6: Line 6:
 
[http://www.neurologyindia.com/article.asp?issn=0028-3886;year=2019;volume=67;issue=3;spage=717;epage=723;aulast=Arora Duchenne muscular dystrophy: Still an incurable disease]
 
[http://www.neurologyindia.com/article.asp?issn=0028-3886;year=2019;volume=67;issue=3;spage=717;epage=723;aulast=Arora Duchenne muscular dystrophy: Still an incurable disease]
  
[https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5010191/
+
[https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5010191/ Long-Term Efficacy, Safety, and Pharmacokinetics of Drisapersen in Duchenne Muscular Dystrophy: Results from an Open-Label Extension Study]
Long-Term Efficacy, Safety, and Pharmacokinetics of Drisapersen in Duchenne Muscular Dystrophy: Results from an Open-Label Extension Study]
 
  
 
{{refs}}
 
{{refs}}

Revision as of 23:30, 11 September 2019